Check Website Status Verify The Latest News New FDA Warning Letters Further Complicate Delta-8 THC Sales Earlier this month, the U.S. Food and Drug Administration (FDA) for the first time issued warning letters regarding products that contain delta-8 THC. Letters were issued to five companies that were marketing products labeled as containing delta-8 THC in ways that, according to the FDA, violate the Federal Food, Drug, and Cosmetic Act (FDCA). Additionally,… By David Khalaf on May 16, 2022 CBD & Cannabis, Controlled Substances & Psychoactives National Fentanyl Awareness Day Highlights the Recent Surge in Opioid-related Deaths In response to the ongoing opioid crisis, the US Senate this year introduced a resolution designating May 10, 2022, as National Fentanyl Awareness Day. The move highlights the increasing danger fentanyl and other dangerous synthetic opioids pose to public health, and it stresses the importance of keeping these opioid sellers off social media and e-commerce… By David Khalaf on May 10, 2022 Addiction Treatment, Controlled Substances & Psychoactives, Pharmacies & Healthcare Merchant Risk Live Wrap-up: Gerard Olson on Cannabis, CBD, and Marijuana What’s the latest on cannabis, marijuana, and CBD? In this episode of Merchant Risk Live, we talk with Gerard Olson, Associate General Counsel at LegitScript, who studies the complex world of cannabis regulation and tracks trends and regulatory changes in the industry. He answers listener questions about recent federal laws to legalize marijuana, risks of… By LegitScript Folks on April 29, 2022 CBD & Cannabis Visit Our Blog for More Updates Get the Latest News